Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation

Mesenchymal stem cell (MSC)-based cell therapy has been demonstrated as a promising strategy in the treatment of inflammatory bowel disease (IBD), which is considered an immune disease. While the exact mechanisms underlying the therapeutic effect of MSCs are still unclear, MSCs display anti-inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fu Yuan, Chen, Rui, Zhang, Xiaohu, Huang, Biao, Tsang, Lai Ling, Li, Xican, Jiang, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168994/
https://www.ncbi.nlm.nih.gov/pubmed/30095002
http://dx.doi.org/10.1177/0963689718780304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168994/
https://www.ncbi.nlm.nih.gov/pubmed/30095002
http://dx.doi.org/10.1177/0963689718780304

Ejemplares similares